Newlink Genetics reported $85.45M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 456.17M 14.87M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Capricor Therapeutics CAPR:US $ 58.07M 6.86M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Idera Pharmaceuticals IDRA:US $ 26.31M 3.83M
Intrexon XON:US $ 321.22M 14.34M
Nektar Therapeutics NKTR:US $ 861.99M 162.13M
Newlink Genetics NLNK:US $ 85.45M 7.74M
Prothena PRTA:US $ 549.59M 31.82M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
YTE INCY:US $ 5319.04M 264.81M